文献速递消化道肿瘤与早癌

肠道菌群调节T细胞向人结直肠癌的迁移

Gut microbiota modulate T cell trafficking into human colorectal cancer.
PubMed 文献 · Gut · 2018-02-06

该研究通过定量逆转录PCR、流式细胞术、体内外模型及16SrRNA测序,探讨趋化因子吸引T细胞进入人结直肠癌的机制及其微环境触发因素。发现不同T细胞亚群浸润与特定趋化因子基因特征相关,肠道菌群可刺激肿瘤细胞产生趋化因子,从而促进有益T细胞募集;特定细菌丰度与高趋化因子表达、增强的T细胞浸润及改善的生存相关。

要点

  • 不同T细胞亚群浸润结直肠癌与特定趋化因子基因特征相关。
  • 肠道菌群在体内外刺激结直肠癌细胞产生趋化因子。
  • 特定细菌丰度与高趋化因子表达、增强T细胞浸润及改善生存相关。

核心结论

  • 肠道菌群刺激结直肠癌细胞产生趋化因子,从而促进有益T细胞募集至肿瘤组织。

研究设计与样本

  • 在新鲜结直肠癌样本及对应无瘤组织中用定量逆转录PCR评估免疫细胞标志物、趋化因子及细菌16S核糖体RNA基因表达。
  • 对消化组织细胞悬液用流式细胞术评估肿瘤浸润淋巴细胞的趋化因子受体表达。
  • 在免疫缺陷小鼠中建立腹腔或盲肠内肿瘤异种移植模型,于体内外评估结直肠癌细胞的趋化因子产生。
  • 将人肿瘤浸润淋巴细胞过继转移至荷瘤小鼠以评估T细胞迁移。
  • 用16SrRNA测序分析肠道菌群组成。

主要发现

  • 细胞毒性T淋巴细胞和Th1细胞浸润与CCL5、CXCL9和CXCL10相关;Th1和调节性T细胞与CCL17、CCL22和CXCL12相关;滤泡性Th细胞与CXCL13相关;产生IL-17的Th细胞与CCL20和CCL17相关。
  • 这些趋化因子在体外和体内由暴露于肠道细菌的肿瘤细胞表达。
  • 趋化因子表达在盲肠内异种移植中显著高于腹腔内异种移植,且经抗生素治疗的荷瘤小鼠中急剧降低。
  • 在临床样本中,特定细菌的丰度与高趋化因子表达、增强的T细胞浸润及改善的生存相关。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Tumour-infiltrating lymphocytes (TILs) favour survival in human colorectal cancer (CRC). Chemotactic factors underlying their recruitment remain undefined. We investigated chemokines attracting T cells into human CRCs, their cellular sources and microenvironmental triggers. DESIGN: Expression of genes encoding immune cell markers, chemokines and bacterial 16S ribosomal RNA (16SrRNA) was assessed by quantitative reverse transcription-PCR in fresh CRC samples and corresponding tumour-free tissues. Chemokine receptor expression on TILs was evaluated by flow cytometry on cell suspensions from digested tissues. Chemokine production by CRC cells was evaluated in vitro and in vivo, on generation of intraperitoneal or intracecal tumour xenografts in immune-deficient mice. T cell trafficking was assessed on adoptive transfer of human TILs into tumour-bearing mice. Gut flora composition was analysed by 16SrRNA sequencing. RESULTS: CRC infiltration by distinct T cell subsets was associated with defined chemokine gene signatures, including CCL5, CXCL9 and CXCL10 for cytotoxic T lymphocytes and T-helper (Th)1 cells; CCL17, CCL22 and CXCL12 for Th1 and regulatory T cells; CXCL13 for follicular Th cells; and CCL20 and CCL17 for interleukin (IL)-17-producing Th cells. These chemokines were expressed by tumour cells on exposure to gut bacteria in vitro and in vivo. Their expression was significantly higher in intracecal than in intraperitoneal xenografts and was dramatically reduced by antibiotic treatment of tumour-bearing mice. In clinical samples, abundance of defined bacteria correlated with high chemokine expression, enhanced T cell infiltration and improved survival. CONCLUSIONS: Gut microbiota stimulate chemokine production by CRC cells, thus favouring recruitment of beneficial T cells into tumour tissues.

来源:Gut,查看原文。版权归原作者所有。

引用

  1. Cremonesi E, Governa V, Garzon JFG, et al. Gut microbiota modulate T cell trafficking into human colorectal cancer. Gut. 2018. PMID: 29437871. doi:10.1136/gutjnl-2016-313498

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。